Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

POLYSPORIN

BACITRACIN ZINC; POLYMYXIN B SULFATE

Standard Dose
10,000 UNITS/GM;2,000,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview POLYSPORIN is listed in Drugs@FDA under application 050167 (NDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength AEROSOL;TOPICAL - 10,000 UNITS/GM;2,000,000 UNITS/GM Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview POLYSPORIN is listed in Drugs@FDA under application 050167 (NDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength AEROSOL;TOPICAL - 10,000 UNITS/GM;2,000,000 UNITS/GM Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.